Abbott/ABT
$104.09
-0.83%-
1D1W1MYTD1YMAX
About Abbott
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.
Ticker
ABT
Sector
Healthcare
Trading on
NYSE
Industry
Medical Equipment & Supplies
CEO
Robert Ford
Employees
114,000
Headquarters
Abbott park, United States
Website
www.abbott.com
Abbott Metrics
BasicAdvanced
$181B
Market cap
32.32
P/E ratio
$3.22
EPS
0.74
Beta
$2.08
Dividend rate
2.11%
Dividend yield
Price and volume
Market cap
$181B
Beta
0.74084
52-week high
$121.64
52-week low
$89.67
Average daily volume
5.8M
Dividend rate
$2.08
Financial strength
Current ratio
1.596
Quick ratio
1.109
Long term debt to equity
32.404
Total debt to equity
37.583
Dividend payout ratio (TTM)
65.63%
Enterprise value to free cash flow
62.478
Interest coverage (TTM)
22.29%
Management effectiveness
Return on assets (TTM)
7.7%
Return on equity (TTM)
14.85%
Return on investment (TTM)
9.6%
Valuation
Price to earnings (TTM)
32.324
Price to revenue (TTM)
4.49
Price to book
4.666
Price to tangible book (TTM)
25.393
Price to free cash flow (TTM)
139.291
Five year average dividend yield
1.52%
Dividend yield (TTM)
2%
Forward dividend yield
2.11%
Growth
Revenue change (TTM)
-2.84%
Earnings per share change (TTM)
-2.38%
3-year revenue growth
5.04%
3-year earnings per share growth
9.13%
3-year dividend per share growth
12.31%
What the Analysts think about Abbott
Analyst Ratings
Majority rating from 25 analysts.
Price Targets
Average projection from 21 analysts.
High $143.00
Low $107.00
$104.09
Current price
$126.23
Average price target
Abbott Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$10B
-2.7%
Net income
$1.2B
-23.15%
Profit margin
12.29%
-21.02%
Abbott Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$1.08
$1.14
$1.19
$0.98
-
Expected
$1.05
$1.10
$1.19
$0.95
$1.11
Surprise
2.89%
3.85%
0.1%
2.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Abbott stock?
Abbott (ABT) has a market cap of $181B as of May 20, 2024.
What is the P/E ratio for Abbott stock?
The price to earnings (P/E) ratio for Abbott (ABT) stock is 32.32 as of May 20, 2024.
Does Abbott stock pay dividends?
Yes, the Abbott (ABT) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $2.08 and the yield is 2.11%. Abbott has a payout ratio of 65.63% on a trailing twelve-month basis.
When is the next Abbott dividend payment date?
The next Abbott (ABT) dividend payment date is unconfirmed.
What is the beta indicator for Abbott?
Abbott (ABT) has a beta rating of 0.74. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Abbott stock price target?
The target price for Abbott (ABT) stock is $126.23, which is 21.27% above the current price of $104.09. This is an average based on projections from 21 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Abbott stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.